$210B
Global supplement market, ~9% annual growth
Thursday, October 29, 2026 · 8:00 PM EDT · Live on Zoom
The market is shifting toward personalized, biomarker-driven care. The practitioners who move first will define the standard.
Webinar Starts In
The question isn't whether this market grows. It's who captures it.
Global supplement market, ~9% annual growth
Personalized nutrition, growing 2× the category
From a single at-home test to a formula that's uniquely theirs — updated every 4 months.
Compatible with epigenetic data, DNA, and standard blood labs - works with what you're already generating.
Research has observed substantial variability in how individuals respond to the same dietary inputs, suggesting that a one-size-fits-all approach to supplementation may leave a significant gap between what a protocol offers and what a specific individual actually needs.1
In an observational study, an individualized wellness program was associated with meaningful changes in CRP levels, an inflammatory marker, over 12 weeks, pointing to the potential value of tailoring protocols to each individual's biology.2
Same category. Different operating system.
One-size-fits-all bottles
Personalize formula built for that individual, dosed to the milligram
Marketing claims, generic RDAs
Epigenetics + blood biomarkers, 900k methylation sites
5-12 pills a day, pill fatigue
One daily pod, 28-day cycle
None - individual buys retail
Full individual panel: biomarkers, adherence, epigenetic age
Static - same formula for years
Retest and re-formulation every 4 months
A deeply personalized supplement pod developed through the Biohax EET guided program.
Protocol built from epigenetics and blood biomarkers. Refined every 4 months.
A live session covering the full Biohax EET guided program.
No cost. A recording goes out to everyone who registers.